Global Hunter Securities Starts Amylin Pharmaceuticals (AMLN) at Accumulate; Bydureon Launch, Ramp Critical to Long-Term Upside

Go back to Global Hunter Securities Starts Amylin Pharmaceuticals (AMLN) at Accumulate; Bydureon Launch, Ramp Critical to Long-Term Upside